Arbutus Biopharma (ABUS) Intangibles (2015 - 2019)
Arbutus Biopharma (ABUS) posted Intangibles of $43.84 million for Q2 2019, down 25.3% from $58.65 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Intangibles (2015 - 2019) Analysis & Trends
Since Q1 2015, Arbutus Biopharma has reported Intangibles for 18 quarters.
- Annual Intangibles has declined for three consecutive years, with a three-year compound annual growth rate of -50.1% (FY2015 to FY2018).
- In prior years, Arbutus Biopharma's Intangibles was $58.65 million in FY2017 (-41.0%), $99.45 million in FY2016 (-71.8%) and $352.64 million in FY2015.
- Quarterly Intangibles has run from a low of $43.84 million in Q3 2018 to a high of $390.02 million in Q2 2015 over five years.
- On a year-over-year basis, Intangibles has declined in each of the last 14 quarters, with an average decline of 38.0% over the last eight quarters.
- Across the past five years, year-over-year decline in Intangibles ran from 9.5% in Q1 2016 to 71.8% in Q4 2016.
- According to Business Quant data, Intangibles for the three prior quarters was $43.84 million (Q1 2019), $43.84 million (Q4 2018) and $43.84 million (Q3 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Arbutus Biopharma | 755.33 Mn | 382.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 43.84 Mn |
| Mar 31, 2019 | 43.84 Mn |
| Dec 31, 2018 | 43.84 Mn |
| Sep 30, 2018 | 43.84 Mn |
| Jun 30, 2018 | 58.65 Mn |
| Mar 31, 2018 | 58.65 Mn |
| Dec 31, 2017 | 58.65 Mn |
| Sep 30, 2017 | 99.45 Mn |
| Jun 30, 2017 | 99.45 Mn |
| Mar 31, 2017 | 99.45 Mn |
| Dec 31, 2016 | 99.45 Mn |
| Sep 30, 2016 | 196.32 Mn |
| Jun 30, 2016 | 196.32 Mn |
| Mar 31, 2016 | 352.64 Mn |
| Dec 31, 2015 | 352.64 Mn |
| Sep 30, 2015 | 353.60 Mn |
| Jun 30, 2015 | 390.02 Mn |
| Mar 31, 2015 | 389.65 Mn |
API Access
Arbutus Biopharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();